CEP350 Activators
Centrosome-associated protein CEP350 is a pivotal element in the maintenance of microtubule organization and centrosomal integrity, with its functional activity being subject to regulation through various signaling pathways. Forskolin, known for its ability to increase intracellular cAMP levels, indirectly augments the functional role of CEP350 via PKA activation. This kinase phosphorylates numerous proteins that converge upon the centrosome, enhancing CEP350's role in microtubule stabilization. Similarly, PMA, through the activation of PKC, phosphorylates substrates that affect cell cycle progression, which could amplify CEP350's role in centrosome cohesion and microtubule tethering. Growth factors such as EGF induce signaling cascades involving the PI3K/AKT pathway, culminating in the modulation of microtubule dynamics; this can potentiate the stability and growth of microtubules where CEP350 is a key player.
Additionally, small molecule modulators like Lithium Chloride and Paclitaxel exert their influence on the microtubule network. Lithium's inhibition of GSK-3 may result in a microtubule landscape favorable to CEP350's structural support function. Paclitaxel exerts its effect by stabilizing microtubules, promoting CEP350-mediated centrosome integrity. On the genetic expression front, compounds like Retinoic Acid and 5-Azacytidine alter differentiation and gene expression patterns, which could lead to an upregulation of proteins that interact with and support CEP350 function. In the realm of phosphorylation regulation, inhibitors of protein phosphatases such as Calyculin A and Okadaic Acid result in an increase in the phosphorylated state of proteins, potentially enhancing the phosphorylation and, therefore, the activity of CEP350. Through these multifaceted mechanisms, the described chemicals serve as indirect activators of CEP350, enhancing its vital functions in cell division and structural organization.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing levels of cAMP. Elevated cAMP enhances PKA activity, which can phosphorylate a multitude of proteins, including those that regulate the assembly and function of the centrosome, where CEP350 is localized and functions. Increased PKA activity can enhance CEP350-mediated microtubule stabilization at the centrosome. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates target proteins involved in cell cycle progression and cytoskeletal organization. PKC activation can lead to the phosphorylation of proteins that interact with CEP350, potentially enhancing CEP350's role in centrosome cohesion and microtubule anchoring. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase-3 (GSK-3). Inhibition of GSK-3 can stabilize microtubules and may enhance the functional activity of CEP350 at the centrosome by maintaining microtubule organization. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules by binding to β-tubulin and inhibiting depolymerization. Stabilized microtubules can enhance the ability of CEP350 to maintain centrosome integrity and function in cell division. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences cellular differentiation and has been shown to affect microtubule dynamics. Its role in differentiation may enhance CEP350 function by promoting the maturation of centrosomes during cell cycle progression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, can alter gene expression patterns. This can lead to changes in the expression of proteins that interact with CEP350, potentially enhancing its function in the centrosome. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins. This increased phosphorylation can enhance CEP350 activity by promoting its association with the centrosome and microtubule stabilization. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to Calyculin A, Okadaic Acid inhibits protein phosphatases, which can lead to an overall increase in protein phosphorylation. This could indirectly enhance CEP350 function by affecting its phosphorylation status and interaction with other centrosomal proteins. | ||||||